Cybin, Inc. (CYBN)
7.17
+0.40
(+5.91%)
USD |
NYAM |
Dec 19, 15:20
Cybin EPS Diluted (Quarterly): -1.393 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Achieve Life Sciences, Inc. | -0.2831 |
| Oncolytics Biotech, Inc. | -0.1032 |
| Aurinia Pharmaceuticals, Inc. | 0.232 |
| Edesa Biotech, Inc. | -0.3157 |
| Lexaria Bioscience Corp. | -0.1378 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -33.72M |
| Total Expenses (Quarterly) | 33.72M |
| Enterprise Value | 282.92M |
| Earnings Yield | -54.23% |
| Normalized Earnings Yield | -52.16 |